Wondering what to buy Fred Hassan and Carrie Cox as leaving presents?
PharmaGossip (Free subscription) | 05/21/2008
How about a cartoon? Hat tip: PM
PharmaGossip (Free subscription) | 05/21/2008
How about a cartoon? Hat tip: PM
Foreign Pharmacy Tips (Free subscription) | 02/13/2008
An American Health Care Story A friend wrote this week with this unhappy news: On Sunday night, my former foster child Josh was beaten up with a baseball bat (after being held up at gunpoint and telling the marauders he had no money) on his... California Shoots Down Gov's Health Care Reform Plan A California Senate committee shot down Gov. Arnold Schwarzenegger's health care reform plan by a 7-1
BrandweekNRX (Free subscription) | 02/12/2008
Based on a recent article in BrandweekNRX, the House Energy & Commerce Committee is widening its investigation into the handling of the ENHANCE trial and about who knew what at Schering-Plough and Merck. Four weeks ago BrandweekNRX revealed that Schering-Plough's...
BrandweekNRX (Free subscription) | 01/30/2008
Evidence has just surfaced that Schering-Plough insiders may have known as early as March 13, 2007 that the ENHANCE trial would not show any statistically significant difference between Vytorin and generic Zocor. What Schering employees knew--and when--is important, since there...
BrandweekNRX (Free subscription) | 01/28/2008
A good magicians always shows the audience what he wants them to see and leads their eyes away from the solution to the tricks he performs before them. Schering-Plough has now employed the same trick, by releasing not just the...
BrandweekNRX (Free subscription) | 01/23/2008
Re: It's official: Congress goes after Carrie Cox All the breifings took place behind closed doors without records or minutes. Congress will no doubt have a very diificult thing finding anything unless they call the people in question to DC...
BrandweekNRX (Free subscription) | 01/22/2008
Here's most recent result from Schering-Plough's message board: More than 90% of those voting want to get rid of Carrie Cox. This one will be interesting to watch--will Teflon-Hassan, who has worked with Carrie for years, throw her to the...
BrandweekNRX (Free subscription) | 01/22/2008
Prescriptions for Merck & Co.'s (MRK) and Schering-Plough Corp.'s (SGP) embattled cholesterol drug Vytorin took a hit last week after a study raised questions about its effectiveness, according to a market-research firm. Total U.S. prescriptions written for Vytorin in the...
BrandweekNRX (Free subscription) | 01/22/2008
It took a little while, but the Securities & Exchange Commission finally visited BrandweekNRX to review information about Schering-Plough President Carrie Cox's sale of $28 million SGP stock in 2007, a year after the failed Vytorin trial was completed and...
BrandweekNRX (Free subscription) | 01/21/2008
Schering-Plough's message board, under the headline "Attention Peter Rost," contained the following threat: "Dr. Rost might need to start sleeping with one eye open if he continues his high level antagonism of huge multinational corporations." Apparently this threat was picked...
BrandweekNRX (Free subscription) | 01/21/2008
Excerpts from The Street: Skip Irvine, director of communications for the joint venture, insists that neither company received any clues about ENHANCE until earlier this month. But skeptics, pointing to stock sales by Schering-Plough insiders, have some doubts. Schering-Plough didn't...
BrandweekNRX (Free subscription) | 01/20/2008
It appears that at least one top executive at Schering-Plough, executive vice president Carrie Cox, sold millions of dollars worth of company stock after the trial ended but before the results were made public. How concerned are you about the...
BrandweekNRX (Free subscription) | 01/20/2008
At least if the poll results on Schering-Plough's message board this weekend are to be believed. And reading the comments over the past week the poll seems to be right on the mark. The second choice is to "Make her...
BrandweekNRX (Free subscription) | 01/18/2008
In the last week Schering-Plough has shed 23.4% of its value. If you believe in buying distressed stock, this is the time to swoop in, right? Not so fast. In a feeble attempt to shore up investor confidence, Schering-Plough CEO...
Health Care Renewal (Free subscription) | 01/18/2008
Back blogging on BrandweekNRX, Dr Peter Rost just posted about the sort of people who now run Schering-Plough, the company that, with Merck Inc, just got a lot of unfavorable publicity after it was involved in delaying the release of results from the ENHANCE trial of ezeimibe (see our last related post here .) According to Rost, " Sean McNicholas is now Schering-Plough's Senior Vice President, responsible...